Major depressive disorder, recurrent episode Recruiting Phase 3 Trials for Psilocybin (DB11664)

Also known as: Depression, Treatment Resistant / Treatment-resistant Depression (TRD) / Resistant Depression, Treatment / Treatment-Resistant Depression / Treatment Resistant Depression (TRD) / Treatment Resistant Depression / Major depressive disorder, recurrent, unspecified / Recurrent major depressive episodes (disorder) / Major depressive disorder, recurrent / Recurrent major depression (disorder) / Treatment resistant depression (disorder) / Depressive Disorder, Treatment-Resistant / Major depressive disorder, single episode, unspecified / Major depressive disorder / Major depressive illness / Major depressive disorder (disorder) / Major depression / Major depressive disorder NOS / Depressive Disorder, Major / Depressive state / Depression NOS / Depressed state / Depression / Depression mental

IndicationStatusPhase
DBCOND0089536 (Major depressive disorder, recurrent episode)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05711940
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDTreatment
NCT05624268
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDTreatment
NCT06303739
Psilocybin-Assisted Therapy in Treatment-Resistant DepressionTreatment